Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Ronald, Bossemeyer"'
Publikováno v:
Maturitas. 56:101-109
Objective To provide uniform, objective guidance for physicians and other health care workers in Latin America to enhance compliance with hormone therapy (HT), and to provide a tool for continued medical education and a source for answering clinical
Autor:
Ronald Bossemeyer, José Mendes Aldrighi, Rosires Pereira de Andrade, J. W. B. Leal, R. Hegg, L. F. Aguiar, L. S. Neto, A. Vara, A. S. Pereira, Ione Cristina Barbosa
Publikováno v:
Gynecological Endocrinology. 10:27-32
The efficacy, tolerability and cycle control of a monophasic oral contraceptive preparation containing gestodene (75μg) plus ethinylestradiol (30 μg) (Minulet®) were studied in 139 women aged over 35 years (mean age 37.12 ± 2.47 years) in a prosp
Publikováno v:
Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology. 23(6)
Trimegestone (TMG) is a novel, 19-norpregnane progestin with potent and selective properties. In preclinical studies, TMG has been shown to provide high endometrial selectivity. Further, TMG has high affinity and selectivity for the progesterone rece
Autor:
Hugo, Maia, Marco Aurélio, Albernaz, Edmund Chada, Baracat, Ione Cristina, Barbosa, Ronald, Bossemeyer, Alberto Hernández, Bueno, Oscar González, Campos, Sebastián, Carranza-Lira, Pedro Figueroa, Casas, Alvaro Monterrosa, Castro, Geraldo Rodrigues, de Lima, Nilson R, de Melo, César Eduardo, Fernandes, Javier Santos, González, Francisco Espinosa, Larrañaga, Néstor, Siseles, Alfonso Murillo, Uribe, Rafael Molina, Vilchez, Latin American Expert Panel
Publikováno v:
Maturitas. 55(1)
Objective Data from placebo-controlled, randomized clinical trials conducted during the past few years resulted in critical re-evaluation of the overall health benefits of hormone therapy (HT) in women during the menopausal transition and thereafter.